Delivery Order SPE2DR25D2108-SPE2DR26F6RG9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Icosapent Ethyl 1 gram capsules (120-count units) with a ceiling value of $3,417.46. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Icosapent Ethyl 1 Gram Capsule 120-count units, with a contract ceiling value of $3,250.80. This non-set-aside award was issued on November 6, 2025, with an ultimate completion date of November 7, 2025, utilizing firm fixed pricing under a delivery order contract type. The pharmaceutical product will be performed at AmerisourceBergen's facility located in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Icosapent Ethyl 1 Gram Capsule (120-count bottles) with a ceiling value of $3,471.13. This is a firm fixed-price delivery order with no set-aside designation, utilizing open competitive procurement. The contract is scheduled for ultimate completion on May 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Icosapent Ethyl 1 Gram Capsule in quantities of 120 units, with a ceiling value of $3,477.08 and a firm fixed price structure. This contract represents a non-set-aside, competitively awarded delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Icosapent Ethyl 1 Gram Capsules (120-count units) under a firm fixed-price contract with a ceiling value of $1,163.46. The delivery order was awarded competitively on December 1, 2025, with a completion date of December 2, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This award utilized no set-aside designation, reflecting the competitive nature of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Icosapent Ethyl 1 gram capsules (120-count). This is a non-set-aside, competitively awarded delivery order with a firm fixed price ceiling of $2,645.61 and an ultimate completion date of December 1, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Icosapent Ethyl 1 Gram Capsule (120-count packages) with a ceiling value of $1,779.42. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract calls for performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, with an ultimate completion date of August 1, 2025. This delivery order is...
- This delivery order, valued at $2,322.47, was awarded to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Icosapent Ethyl 1 gram capsules (120-count units) with an ultimate completion date of October 22, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating it was competitively awarded. The Defense Logistics Agency, which serves the Department of Defense's medical supply chain requirements, is the funding federal agency, and the place of...
- This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Icosapent Ethyl 1 gram capsules. The contract has a ceiling value of $13,274.69 and a completion date of May 16, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive global...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Icosapent Ethyl 1 Gram Capsule 120s, with a ceiling value of $2,053.92 and a completion date of June 10, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DR25D2108Indefinite Delivery Contract
- SPE2DR25D2108-SPE2DR26F6RG9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Icosapent Ethyl 1 Gram Capsule (120-count units) with a ceiling value of $1,055.67. This firm fixed-price delivery order, with an ultimate completion date of December 3, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle, enabling the company to supply a broad range of pharmaceutical products and medical supplies supporting military healthcare programs worldwide. The arrangement reflects the Defense Logistics Agency's strategy to maintain multiple pharmaceutical prime vendors capable of delivering diverse therapeutic medications and medical commodities across multiple regions and customer bases, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/1/25 |